Abstract
A series of aryl and acyclic unsaturated chloromethyl derivatives of thioguanine and 6-mercaptopurine 1-20 were synthesized. These compounds were evaluated for cytotoxic activity against NCI-60 DTP human tumor cell line screen at 10µ Molar concentration. Compound 1 exhibited potent cytotoxic activity with GI50 values 1 - 7 µ Molar range for most human tumor cell lines. Further, compounds 6, 9, 16 exhibited highly significant GI50 values 1 - 3 µ Molar range throghout the entire spectrum of the 60 cell line screen including the colon cancer and CNS cancer. Other compounds exhibited moderate activity.
Keywords: Substituted thioguanine, Substituted 6-mercaptopurine, Cytotoxic activity, Thioguanine, 6-mercaptopurine, HGPRT, MP, mercaptopurine, Selective substitution, DMF medium, leukemia, Non-Small Cell Lung Cancer, RPMI1640, Electrothermal MEL-TEMP appara-tus, Elemental analysis
Letters in Drug Design & Discovery
Title: Aryl and Acyclic Unsaturated Derivatives of Thioguanine and 6- Mercaptopurine: Synthesis and Cytotoxic Activity
Volume: 8 Issue: 8
Author(s): Tien N. Banh, Nageswara R. Kode and Shashikant Phadtare
Affiliation:
Keywords: Substituted thioguanine, Substituted 6-mercaptopurine, Cytotoxic activity, Thioguanine, 6-mercaptopurine, HGPRT, MP, mercaptopurine, Selective substitution, DMF medium, leukemia, Non-Small Cell Lung Cancer, RPMI1640, Electrothermal MEL-TEMP appara-tus, Elemental analysis
Abstract: A series of aryl and acyclic unsaturated chloromethyl derivatives of thioguanine and 6-mercaptopurine 1-20 were synthesized. These compounds were evaluated for cytotoxic activity against NCI-60 DTP human tumor cell line screen at 10µ Molar concentration. Compound 1 exhibited potent cytotoxic activity with GI50 values 1 - 7 µ Molar range for most human tumor cell lines. Further, compounds 6, 9, 16 exhibited highly significant GI50 values 1 - 3 µ Molar range throghout the entire spectrum of the 60 cell line screen including the colon cancer and CNS cancer. Other compounds exhibited moderate activity.
Export Options
About this article
Cite this article as:
N. Banh Tien, R. Kode Nageswara and Phadtare Shashikant, Aryl and Acyclic Unsaturated Derivatives of Thioguanine and 6- Mercaptopurine: Synthesis and Cytotoxic Activity, Letters in Drug Design & Discovery 2011; 8(8) . https://dx.doi.org/10.2174/157018011796576088
DOI https://dx.doi.org/10.2174/157018011796576088 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design Structural and Functional Diversity of Estrogen Receptor Ligands
Current Topics in Medicinal Chemistry Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis
Current Pharmaceutical Design VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Molecular Classification and Drug Response Prediction in Cancer
Current Drug Targets Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Current Pharmaceutical Design Lactoferrin: A Biologically Active Molecule for Bone Regeneration
Current Medicinal Chemistry Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders
Current Molecular Medicine Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Editorial (Thematic Issue: Advances with microRNAs in Tumorigenesis and Cancer Therapy)
Current Pharmaceutical Design Editorial [Hot Topic: ADAMs: Targets for Drug Discovery (Executive Editor: Marcia L. Moss)]
Current Pharmaceutical Design Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Current Medicinal Chemistry MicroRNA and Cancer: Tiny Molecules with Major Implications
Current Genomics Anti-Cancer
Current Bioactive Compounds The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs
Current Pharmaceutical Design Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrinemediated Tissue Repair
Current Stem Cell Research & Therapy Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin
Mini-Reviews in Medicinal Chemistry DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine A Bioinformatics Pipeline for Cancer Epigenetics
Current Bioinformatics Estrogen, Immunity & Autoimmune Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents